Metacognitive Therapy
Metacognitive Therapy is a cognitive-behavioral psychotherapy developed by Adrian Wells in 2009. Its core mechanism: modifying metacognitive beliefs about worry/rumination and detached mindfulness interrupts the Cognitive Attentional Syndrome. This catalogue links it to anxiety, depression and OCD, typically in individual format, short-term.
Related condition topics
These links support exploration. They do not establish that Metacognitive Therapy is effective or recommended for each condition.
How Metacognitive Therapy works
Modifying metacognitive beliefs about worry/rumination + detached mindfulness interrupts the Cognitive Attentional Syndrome
Ontology
Not the content of thoughts but metacognitive beliefs about thinking (worry is useful/uncontrollable) maintain disorder
Therapeutic Voice
"You've told me the worry is uncontrollable, that once it starts it runs you. So let's test that one: when it starts tomorrow, park it until six o'clock and see what happens."
View of the Person
A being trapped not by thought content but by metacognitive beliefs about thinking itself (e.g., worry is useful/uncontrollable)
Epistemology
Evidence
2 condition assessments available
An overall effectiveness assessment has not been completed. Completed assessments for specific populations appear below.
Condition-specific assessments
Each conclusion applies to the population and use described. These source-based assessments do not certify the full entry or replace expert clinical review.
Anxiety Disorders
Population and scope: Adults with long-standing generalized anxiety disorder treated with Wells-model metacognitive therapy at a Norwegian university outpatient clinic.
Randomized studies
Nordahl et al. randomized 81 patients to metacognitive therapy, CBT or waiting list. Both therapies improved outcomes; metacognitive therapy showed greater improvement on the primary worry measure than CBT, with differences maintained at two years. Outcomes were predominantly self-reported and the planned one-year follow-up was abandoned after collection problems. This comparison concerns GAD and the studied protocols, not superiority for all anxiety disorders.
Source assessment dated
Depression & Mood Disorders
Population and scope: Adults with major depressive disorder in a Danish primary-care outpatient clinic, in Callesen et al.'s 2020 MCT-versus-CBT trial.
Randomized studies
The trial randomized 174 adults; 155 remained after withdrawals of consent. MCT improved the self-reported BDI-II co-primary outcome more than CBT, but the observer-rated HDRS co-primary outcome did not differ significantly. The same pattern held at six-month follow-up. Only two therapists delivered treatment, and the MCT originator's involvement and post-randomization exclusions limit inference. The results support randomized evaluation with outcome-dependent findings, not unqualified superiority over CBT.
Source assessment dated
Guidelines and official sources (4)
4 clinical guideline checks
Read the recommendation and its scope. A source may discuss an approach without recommending it.
- Management of Major Depressive Disorder
Discussed in the source
VA/DoD discusses a metacognitive-therapy trial within CBT-package comparisons, without issuing a separate recommendation for Wells’s protocol or establishing its superiority.
Scope: Adults with MDD; Wells metacognitive therapy compared with CBT.
- Management of First-Episode Psychosis and Schizophrenia
Discussed in the source
The guideline’s metacognitive intervention uses cognitive-bias training and discusses MERIT. Its weak-for recommendation should not be attributed to Adrian Wells’s metacognitive therapy.
Scope: Schizophrenia-focused metacognitive training; a different intervention from Wells’s therapy.
- Clinical Practice Guideline for the Treatment of Posttraumatic Stress Disorder in Adults
Insufficient evidence for or against
APA finds insufficient evidence to recommend for or against metacognitive therapy in this comparison.
Scope: Adults with PTSD; metacognitive therapy versus no intervention or usual care.
- Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders
Discussed in the source
Metacognitive therapy is named in the reviewed third-wave therapy category. WHO recommends that category alongside other structured therapies; it does not give metacognitive therapy a separate recommendation or separate certainty rating here.
Scope: Adults with moderate-to-severe depression, within the mhGAP non-specialist-care context.
Recorded material under review
The existing notes below are retained separately from assessment records. These recorded claims await source checking, including study design, recommendations and numerical estimates.
15+ RCTs
Normann & Morina (2018)
Strong evidence emerging. Large effect sizes. Head-to-head with CBT shows comparable or superior effects.
Training and certification
MCT workshop (2-3 days) + supervised practice. Distinct from standard CBT
MCT Institute: practitioner diploma
Foundation: 16-24 hrs; diploma additional
$1K-3K
Clinical cautions and blind spots
Assessment and precautions
Active psychosis with disorganized thought, severe cognitive impairment, clients unable to adopt a meta-perspective on their own thinking, acute crisis requiring immediate safety planning
Blind spots
Narrow focus on metacognitive beliefs may miss relational and developmental dimensions; relatively new evidence base
Philosophical roots
Wells (metacognitive model); Flavell (metacognition research); distinct from Buddhist mindfulness despite surface similarity: targets beliefs about thinking, not present-moment awareness
Compared with other approaches
Metacognitive Therapy in 1 Comparative Clinical Vignette
Each vignette presents the same client through multiple theoretical lenses side by side — showing how Metacognitive Therapy formulates presenting problems, sets treatment focus, and sounds in the consulting room compared with other approaches. This comparative pedagogy is unique to Epoché Clinical; no other clinical reference systematically formulates the same case across traditions.
Test Yourself
MCT vs. standard CBT?
Show answer
CBT challenges thought content; MCT targets beliefs about thinking itself.